Sequencing and Tracking of Phylogeny in COVID-19 Study
STOPCOVID19
1 other identifier
observational
5,602
1 country
1
Brief Summary
The Investigators plan to generate a database of viral RNA sequences for SARS-CoV-2 within the Wessex region. Such whole genome data can be used to monitor mutation rates in real time and, through comparison with global databases of SARS-CoV-2 genome sequences, can be used to map transmission of the virus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedStudy Start
First participant enrolled
May 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedApril 3, 2023
January 1, 2023
2.4 years
April 20, 2020
March 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of whole genome sequences for the SARS-CoV-2 virus from viral RNA samples
Generated using Nanopore-based whole genome sequencing techniques
2 years
Secondary Outcomes (1)
Transmission rates of the SARS-CoV-2 virus
2 years
Eligibility Criteria
Focus on those whose tests have provided a positive result so as to maximise the number of SARS-CoV-2 genomes generated.
You may qualify if:
- Have undergone successful testing for Covid-19
- Have sufficient viral RNA remaining for research analysis following testing for Covid-19
You may not qualify if:
- Insufficient viral RNA remains following testing for Covid-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Portsmouth Hospitals NHS Trustlead
- University of Portsmouthcollaborator
Study Sites (1)
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, PO6 3LY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2020
First Posted
April 24, 2020
Study Start
May 4, 2020
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
April 3, 2023
Record last verified: 2023-01